Google's Larry Page and Sergey Brin Plan to Cure Aging with Biotech Venture

Google Inc.'s (Nasdaq: GOOG, GOOGL) Larry Page and Sergey Brin have taken anti-aging to a whole new level. In 2013, Google founded the biotech company Calico along with Apple Inc. (Nasdaq: AAPL) Chairman Arthur Levinson. Rather than focusing on diseases, Calico was founded to cure aging. According to Page, expanding the human life span by as much as 100 years is the company's goal. Thanks to new breakthroughs, they may be closer than you think... Tags: anti aging , biological immortality , biotech companies , biotech stocks , Calico , GOOG , Google Calico , google stock , how to live forever , larry page , Larry Page and Sergey Brin , larry page sergey brin , living forever , Nasdaq: GOOG , sergey brin To get full access to all Money Morning content, click here About Money Morning: Money Morning gives you access to a team of ten market experts with more than 250 years of combined investing experience – for free . Our experts – who have appeared on FOXBusiness, CNBC, NPR, and BloombergTV – deliver daily investing tips and stock picks, provide analysis with actions to take, and answer your biggest market questions. Our goal is to help our millions of e-newsletter subscribers and Moneymorning.com visitors become smarter, more confident investors. Disclaimer: © 2015 Money Morning and Money Map Press. All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning. 16 W. Madison St. Baltimore, MD, 21201. The post Google's Larry Page and Sergey Brin Plan to Cure Aging with Biotech Venture appeared first on Money Morning - We Make Investing Profitable .
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.